Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

NEW YORK, Jan. 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

http://www.reportlinker.com/p0848584/Facial-Aesthetics-Botulinum-Toxin-Dermal-Fillers---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cosmetic_Surgery

Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

 

Summary

GlobalData's new report, "Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global facial aesthetics market. It gives the market landscape, competitive landscape and market trends information for the facial aesthetics market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

- The key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers).

- Annualized market revenue data for 2011 and forecast forward to 2018, as well as company shares data for 2011. Company shares data for Botox and Dermal Fillers for 2011 are also provided.

- Qualitative analysis of key market trends, market drivers, and restraints within the facial aesthetics market.

- Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- The key players covered are Allergan, Q-Med, Mentor, Medicis and Merz.

 

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the facial aesthetics market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.

- What's the next big thing in the facial aesthetics market landscape? Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.

 

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 GlobalData Report Guidance 7

3 Facial Aesthetics - Device Overview 8

3.1 Botulinum Toxin 8

3.2 Dermal Fillers 8

3.2.1 Hyaluronic Acid Based Dermal Fillers 8

3.2.2 Other Dermal Fillers 9

4 Facial Aesthetics - Global Market Characterization 10

4.1 Facial Aesthetics Market, Global, Revenue ($bn), Forecast, 2011-2018 10

4.2 Facial Aesthetics Market, Key Trends 11

4.2.1 Hyaluronic Acid Based Dermal Fillers to Drive the Market for Facial Aesthetics in the Future 11

4.2.2 Inception of Hyaluronic Acid Based Dermal Fillers has led to the Decline of Collagen Products 11

4.3 Facial Aesthetics, Market Dynamics 12

4.3.1 Market Drivers 13

4.3.2 Market Restraints 14

5 Facial Aesthetics Market - Segment Analysis 16

5.1 Botulinum Toxin, Global, Revenue ($bn), Forecast, 2011–2018 16

5.2 Botulinum Toxin, Market Dynamics 17

5.2.1 Key Market Drivers: Increasing Number of Procedures and Reducing Price Trend 17

5.2.2 Market Growth Restraints: High Side Effects Profile and Temporary Results of Botulinum Toxin 18

5.3 Dermal Fillers, Global, Revenue ($m), Forecast, 2011–2018 19

5.4 Dermal Fillers, Market Dynamics 20

5.4.1 Market Drivers 20

5.4.2 Market Restraint 21

6 Facial Aesthetics Market, by Country, 2011–2018 22

6.1 Facial Aesthetics Market, the US, Revenue ($m), Forecast, 2011–2018 22

6.2 Facial Aesthetics Market, Canada, Revenue ($m), Forecast, 2011–2018 24

6.3 Facial Aesthetics Market, the UK, Revenue ($m), Forecast, 2011–2018 26

6.4 Facial Aesthetics Market, Germany, Revenue ($m), Forecast, 2011–2018 28

6.5 Facial Aesthetics Market, France, Revenue ($m), Forecast, 2011–2018 30

6.6 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2011–2018 32

6.7 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2011–2018 34

6.8 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2011–2018 36

6.9 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2011–2018 38

6.10 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2011–2018 40

6.11 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2011–2018 42

6.12 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2011–2018 44

7 Global Facial Aesthetics Market - Strategic Competitive Assessment 46

7.1 Facial Aesthetics Market, Global, Company Share (%), 2011 46

7.2 Botulinum Toxin Market, Global, Company Share (%), 2011 47

7.3 Dermal Fillers Market, Global, Company Share (%), 2011 48

7.4 Facial Aesthetics, Market Opportunities and Risk Evaluation 50

7.4.1 Opportunities 50

7.4.2 Risks 51

7.5 Facial Aesthetics Market, Key Market Participants 51

7.5.1 Allergan, Inc 51

7.5.2 Q-Med AB (Subsidiary of Galderma S.A.) 54

7.5.3 Medicis Pharmaceuticals Corporation 59

7.5.4 Merz GmbH & Co. KGaA 60

8 Facial Aesthetics Market – Strategic Pipeline Assessment 64

8.1 Dermal Fillers Market, List of Pipeline Products, Global, 2011 64

8.2 Profiles of Pipeline Products in Facial Aesthetics Market 65

8.2.1 Aeon Astron Corporation: Aeon Dermal Filler 65

8.2.2 Contura International A/S: Aquamid 65

8.2.3 Merz Pharma GmbH & Co. KgaA: Belotero Soft 65

8.2.4 Mosaic Medical Technologies, Inc: Dermal Filler 66

8.2.5 Allergan, Inc.: Juvederm Voluma 66

8.2.6 Q-Med AB: Macrolane 66

8.2.7 Q-Med AB: Restylane Touch 67

8.2.8 EternoGen, LLC: Aesthetic Procedures 67

8.2.9 Anika Therapeutics, Inc.: Next Generation Elevess Dermal Filler 67

8.2.10 FibroGen, Inc. FG-5030 68

8.2.11 Prollenium Medical Technologies, Inc: Revanesse Ultra 68

8.2.12 TEI Biosciences Inc.: Injectable Dermal Fille 68

8.2.13 Mentor Worldwide LLC: Puragen 69

8.2.14 Mentor Worldwide LLC: Puragen Plus 69

8.2.15 Teoxane laboratories: Teosyal Deep Lines 69

8.2.16 Teoxane laboratories: Teosyal First Lines 70

8.2.17 Teoxane laboratories: Teosyal Global Action 70

8.2.18 Teoxane laboratories: Teosyal Kiss 70

8.2.19 Teoxane laboratories: Teosyal Meso 71

8.2.20 Teoxane laboratories: Teosyal Touch Up 71

8.2.21 Teoxane laboratories: Teosyal Ultra Deep 71

8.3 Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72

8.3.1 Revance Therapeutics, Inc.: RT001 72

8.3.2 Q-Med AB: Azzalure 72

8.3.3 Johnson & Johnson: PurTox 73

9 Appendix 74

9.1 Definitions 74

9.1.1 Facial Aesthetics 74

9.2 Acronyms 75

9.3 Sources 75

9.4 Research Methodology 76

9.5 Secondary Research 76

9.6 Primary Research 77

9.7 Models 77

9.8 Forecasts 77

9.9 Expert Panels 78

9.10 GlobalData Consulting 78

9.11 Contact Us 78

9.12 Disclaimer 78

 

List of Tables

Table 1: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018 10

Table 2: Collagen Products, The US, Number of Procedures (000's), 2000–2011 11

Table 3: Botulinum Toxin, Global, Revenue ($bn), 2011–2018 16

Table 4: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011 17

Table 5: Dermal Fillers, Global, Revenue ($m), 2011–2018 19

Table 6: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011 20

Table 7: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018 22

Table 8: Facial Aesthetics Market, the US, Procedures (million), 2011 23

Table 9: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018 24

Table 10: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25

Table 11: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018 26

Table 12: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27

Table 13: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018 28

Table 14: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29

Table 15: Facial Aesthetics Market, France, Revenue ($m), 2011–2018 30

Table 16: Facial Aesthetics Market, France, Procedures (000's), 2011 31

Table 17: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018 32

Table 18: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33

Table 19: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018 34

Table 20: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35

Table 21: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018 36

Table 22: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37

Table 23: Facial Aesthetics Market, China, Revenue ($m), 2011–2018 38

Table 24: Facial Aesthetics Market, China, Procedures (000's), 2011 39

Table 25: Facial Aesthetics Market, India, Revenue ($m), 2011–2018 40

Table 26: Facial Aesthetics Market, India, Procedures (000's), 2011 41

Table 27: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018 42

Table 28: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43

Table 29: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018 44

Table 30: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45

Table 31: Facial Aesthetics Market, Global, Revenue by Company ($m), 2011 46

Table 32: Botulinum Toxin Market, Global, Revenue by Company ($m), 2011 47

Table 33: Dermal Fillers Market, Global, Revenue by Company ($m), 2011 48

Table 34: Allergan, Key Marketed Products, Applications, Features and Benefits, 2012 52

Table 35: Safety and Effectiveness of Juvederm Injectable Gel with Lidocaine 52

Table 36: Allergan Inc., Acquires Groupe Corneal Laboratories SA, 2007 53

Table 37: Q-Med AB, Key Marketed Products, Applications, Features and Benefits, 2012 54

Table 38: Galderma Acquires Q–Med AB, 2011 55

Table 39: Mentor Worldwide, Key Marketed Products, Applications, Features and Benefits, 2012 57

Table 40: Reduced Pain With Use Of Proprietary Hyaluronic Acid With Lidocaine For Correction Of Nasolabial Folds: A Patient-Blinded, Prospective, Randomized Controlled Trial 57

Table 41: Johnson & Johnson Acquires Mentor Corporation, 2009 57

Table 42: Medicis, Key Marketed Products, Applications, Features and Benefits, 2011 59

Table 43: Merz GmbH & Co. KGaA, Key Marketed Products, Applications, Features and Benefits, 2012 61

Table 44: Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse Injectable Dermal Filler for the Treatment of Nasolabial Folds 61

Table 45: Merz Pharma Completes The Acquisition of BioForm Medical, 2010 62

Table 46: Dermal Fillers Market, List of Pipeline Products, Global, 2011 64

Table 47: Aeon Dermal Filler, Product Status 65

Table 48: Aquamid, Product Status 65

Table 49: Belotero Soft, Product Status 65

Table 50: Dermal Filler, Product Status 66

Table 51: Juvederm Voluma, Product Status 66

Table 52: Macrolane, Product Status 66

Table 53: Restylane Touch, Product Status 67

Table 54: Dermal Filler - Aesthetic Procedures, Product Status 67

Table 55: Next Generation Elevess Dermal Filler, Product Status 67

Table 56: FG-5030, Product Status 68

Table 57: Revanesse Ultra, Product Status 68

Table 58: Injectable Dermal Filler, Product Status 68

Table 59: Puragen, Product Status 69

Table 60: Puragen Plus, Product Status 69

Table 61: Teosyal Deep Lines, Product Status 69

Table 62: Teosyal First Lines, Product Status 70

Table 63: Teosyal Global Action, Product Status 70

Table 64: Teosyal Kiss, Product Status 70

Table 65: Teosyal Meso, Product Status 71

Table 66: Teosyal Touch Up, Product Status 71

Table 67: Teosyal Ultra Deep, Product Status 71

Table 68: Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72

Table 69: RT001, Product Status 72

Table 70: Azzalure, Product Status 72

Table 71: PurTox, Product Status 73

 

List of Figures

Figure 1: Facial Aesthetics Market, Market Segmentation, 2012 8

Figure 2: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018 10

Figure 3: Collagen Products, The US, Number of Procedures (000's), 2000–2011 11

Figure 4: Facial Aesthetics, Market Dynamics 12

Figure 5: Botulinum Toxin, Global, Revenue ($bn), 2011–2018 16

Figure 6: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011 17

Figure 7: Dermal Fillers, Global, Revenue ($m), 2011–2018 19

Figure 8: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011 20

Figure 9: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018 22

Figure 10: Facial Aesthetics Market, the US, Procedures (million), 2011 23

Figure 11: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018 24

Figure 12: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25

Figure 13: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018 26

Figure 14: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27

Figure 15: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018 28

Figure 16: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29

Figure 17: Facial Aesthetics Market, France, Revenue ($m), 2011–2018 30

Figure 18: Facial Aesthetics Market, France, Procedures (000's), 2011 31

Figure 19: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018 32

Figure 20: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33

Figure 21: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018 34

Figure 22: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35

Figure 23: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018 36

Figure 24: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37

Figure 25: Facial Aesthetics Market, China, Revenue ($m), 2011–2018 38

Figure 26: Facial Aesthetics Market, China, Procedures (000's), 2011 39

Figure 27: Facial Aesthetics Market, India, Revenue ($m), 2011–2018 40

Figure 28: Facial Aesthetics Market, India, Procedures (000's), 2011 41

Figure 29: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018 42

Figure 30: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43

Figure 31: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018 44

Figure 32: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45

Figure 33: Facial Aesthetics Market, Global, Company Share (%), 2011 46

Figure 34: Botulinum Toxin Market, Global, Company Share (%), 2011 47

Figure 35: Dermal Fillers Market, Global, Company Share (%), 2011 48

Figure 36: Botulinum Toxin Product Benchmarking 49

Figure 37: Hyaluronic Acid Based Dermal Fillers Product Benchmarking 49

Figure 38: Facial Aesthetics, Market Opportunities and Risk Evaluation, 2011 50

Figure 39: Allergan Inc., Internal Factor Analysis, 2012 53

Figure 40: Q-Med AB, Internal Factor Analysis, 2012 55

Figure 41: Mentor Worldwide, Internal Factor Analysis, 2012 58

Figure 42: Medicis Pharmaceutical Corporation, Internal Factor Analysis, 2012 60

Figure 43: Merz GmbH & Co. KGaA, Internal Factor Analysis, 2012 62

 

Companies mentioned

Allergan, Inc

Q-Med AB (Subsidiary of Galderma S.A.)

Mentor Worldwide LLC (Subsidiary of Ethicon, Inc.)

Medicis Pharmaceuticals Corporation

Merz GmbH & Co. KGaA

 

To order this report:

: Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.